Skip to main content

Advertisement

SpringerLink
Log in

Risk Factors for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background and objectives

Hepatic resection is established as the treatment for HCC. However, patients sometimes experience early recurrence of HCC (ER HCC) after curative resection.

Methods

A retrospective analysis was conducted for 193 patients with single HCC who underwent curative liver resection in our medical center between April 2000 and March 2013. We divided the cohort into two groups; early recurrence group (ER G) which experienced recurrence within 6 months after resection, and non-early recurrence group (NER G). Risk factors for ER HCC were analyzed.

Results

Thirty-nine out of 193 (20.2 %) patients had ER HCC. Univariate analysis showed Glasgow prognostic score (GPS, p = 0.036), neutrophil to lymphocyte ratio (NLR, p = 0.001), level of PIVKA-II (p = 0.0001), level of AFP (p = 0.0001), amounts of blood loss (p = 0.001), operating time (p = 0.002), tumor size (p = 0.0001), stage III and IV (p = 0.0001), and microvascular invasions (portal vein: p = 0.0001 and hepatic vein: p = 0.001) to be associated with ER HCC. By multivariate analysis, there were significant differences in high NLR (p = 0.029) and high AFP (p = 0.0001) in patients with ER HCC.

Conclusions

Preoperative high AFP (more than 250 ng/ml) and high NLR (more than 1.829) were independent risk factors for ER HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kudo M, Izumi N, Kokudo N et al (2011) Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 29(3):339–364

    Article  PubMed  Google Scholar 

  2. Bruix J, Sherman M (2005) Practice Guidelines Committee AAftSoLD. Management of hepatocellular carcinoma. Hepatology 42(5):1208–1236

    Article  PubMed  Google Scholar 

  3. Lim KC, Chow PK, Allen JC et al (2012) Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg 99(12):1622–1629

    Article  PubMed  Google Scholar 

  4. Shirabe K, Kanematsu T, Matsumata T et al (1991) Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 14(5):802–805

    Article  CAS  PubMed  Google Scholar 

  5. Poon RT, Fan ST, Lo CM et al (2002) Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235(3):373–382

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sohn W, Paik YH, Kim JM et al (2014) HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma. Ann Surg Oncol 21(7):2429–2435

    Article  PubMed  Google Scholar 

  7. Zhu WJ, Huang CY, Li C et al (2013) Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection. Asian Pac J Cancer Prev 14(12):7101–7106

    Article  PubMed  Google Scholar 

  8. Li T, Qin LX, Gong X et al (2014) Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma. Surgery 156(3):651–660

    Article  PubMed  Google Scholar 

  9. Ishizuka M, Kubota K, Kita J et al (2012) Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patients. Am J Surg 203(1):101–106

    Article  PubMed  Google Scholar 

  10. Walsh SR, Cook EJ, Goulder F et al (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91(3):181–184

    Article  CAS  PubMed  Google Scholar 

  11. Gomez D, Farid S, Malik HZ et al (2008) Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 32(8):1757–1762

    Article  CAS  PubMed  Google Scholar 

  12. Ishizuka M, Oyama Y, Abe A, Kubota K (2014) Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer. J Surg Oncol 110(8):935–941

    Article  PubMed  Google Scholar 

  13. Feng JF, Huang Y, Chen QX (2014) The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma. Transl Oncol 7(5):632–637

    Article  PubMed  PubMed Central  Google Scholar 

  14. McMillan DC (2013) The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39(5):534–540

    Article  PubMed  Google Scholar 

  15. Liao R, Tang ZW, Li DW et al (2015) Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report. World J Surg Oncol 13:265

    Article  PubMed  PubMed Central  Google Scholar 

  16. Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161(4):346–350

    CAS  PubMed  Google Scholar 

  17. Zhou YM, Yang JM, Li B et al (2010) Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreat Dis Int 9(1):33–37

    PubMed  Google Scholar 

  18. Du ZG, Wei YG, Chen KF, Li B (2014) Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution’s experience with 398 consecutive patients. Hepatobiliary Pancreat Dis Int 13(2):153–161

    Article  PubMed  Google Scholar 

  19. Tangkijvanich P, Anukulkarnkusol N, Suwangool P et al (2000) Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 31(4):302–308

    Article  CAS  PubMed  Google Scholar 

  20. Poon RT, Fan ST, Ng IO et al (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89(3):500–507

    Article  CAS  PubMed  Google Scholar 

  21. Shimoda M, Katoh M, Kita J et al (2010) The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer. Chemotherapy 56(6):501–506

    Article  CAS  PubMed  Google Scholar 

  22. Ishizuka M, Kubota K, Kita J et al (2011) Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma. J Surg Oncol 103(8):801–806

    Article  PubMed  Google Scholar 

  23. Li C, Wen TF, Yan LN et al (2015) Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma. J Surg Res 198(1):73–79

    Article  PubMed  Google Scholar 

  24. Peng W, Li C, Wen TF et al (2014) Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival. J Surg Res 192(2):402–408

    Article  PubMed  Google Scholar 

  25. Mano Y, Shirabe K, Yamashita Y et al (2013) Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg 258(2):301–305

    Article  PubMed  Google Scholar 

  26. Yamamura K, Sugimoto H, Kanda M et al (2014) Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. J Hepatobiliary Pancreat Sci 21(9):682–688

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterological Surgery, Tokyo Medical University Ibaraki Medical Center, 3-20-1, Ami, Ibaraki, 300-0395, Japan

    Mitsugi Shimoda

  2. Second Department of Surgery, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan

    Kazuma Tago, Takayuki Shiraki, Shozo Mori, Masato Kato, Taku Aoki & Keiichi Kubota

Authors
  1. Mitsugi Shimoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuma Tago
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takayuki Shiraki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shozo Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masato Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Taku Aoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Keiichi Kubota
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsugi Shimoda.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shimoda, M., Tago, K., Shiraki, T. et al. Risk Factors for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection. World J Surg 40, 2466–2471 (2016). https://doi.org/10.1007/s00268-016-3529-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-016-3529-7

Keywords

Search

Navigation